A Study of Patients With Chronic Disease
Stopped early
Conditions studied: Asthma, Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, IPF, COPD, Respiratory Disease
In brief
TARGET-RWE is a 10-year, international, longitudinal, observational study of patients with chronic disease designed to specifically address important clinical questions that remain incompletely answered from registration trials. The protocol will follow a master protocol design in which a shared study infrastructure supports progressive development of the registry across the spectrum of chronic diseases.
Key facts
- Study ID
- NCT04263727
- Run by
- Target PharmaSolutions, Inc.
- People needed
- 579
- Starts
- 2020-02-27
- Expected to finish
- 2024-11-21
- Last updated by the study team
- 2025-04-03
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults and children being managed or treated for a chronic disease under study. Diagnosis is based on the clinical judgement of the care provider.
- Patient is anticipated to have continued management of their chronic disease at the participating site.
You may not qualify if…
- Inability to provide informed assent/consent.
Where it is running
- Asthma and Allergy Associates, PC — Colorado Springs, Colorado, United States
- St. Francis Medical Institute — Clearwater, Florida, United States
- Family Allergy & Asthma Research Institution — Louisville, Kentucky, United States
- University of Michigan Allergy Specialty Clinic & Food Allergy — Ann Arbor, Michigan, United States
- Coastal Carolina Healthcare, P.A. — New Bern, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.